The primary enriched pathways in the Control group are Lipoic acid metabolism and Nicotinate and nicotinamide metabolism, whereas the Experimental group shows significant enrichment in Prion diseases, Chlorocyclohexane and chlorobenzene degradation, Chloroalkane and chloroalkene degradation, *Biofilm formation – Escherichia coli, and Phosphotransferase system (PTS). This evidence concerns the gene PTS and prion disease.